93 related articles for article (PubMed ID: 20156712)
1. [Non-occlusive stent thrombosis associated to cardiocirculatory arrest].
García Paredes T; Escudero Varela JC; Mora Ordóñez JM
Med Intensiva; 2010 Mar; 34(2):157. PubMed ID: 20156712
[No Abstract] [Full Text] [Related]
2. Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.
Murray AT; Sederberg JH
Semin Cardiothorac Vasc Anesth; 2011; 15(1-2):40-3. PubMed ID: 21840879
[TBL] [Abstract][Full Text] [Related]
3. A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy.
Kagawa Y; Shiode N; Kawase T; Tamekiyo H; Okimoto T; Hayashi Y
Cardiovasc Interv Ther; 2017 Apr; 32(2):170-173. PubMed ID: 26979600
[TBL] [Abstract][Full Text] [Related]
4. [Results of using the resolute stent in everyday clinical practice in 5000 patients].
Savchenko AP; Rudenko AP; Cherkavskaia OV
Vestn Rentgenol Radiol; 2010; (4):43-7. PubMed ID: 22187910
[No Abstract] [Full Text] [Related]
5. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should not be continued for more than 1 year and preferably indefinitely.
Colombo A; Gerber RT
Circ Cardiovasc Interv; 2008 Dec; 1(3):226-32. PubMed ID: 20031682
[No Abstract] [Full Text] [Related]
6. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results.
Mirabella F; Francaviglia B; Capodanno D; Di Salvo ME; Galassi AR; Ussia GP; Capranzano P; Tamburino C
J Invasive Cardiol; 2009 Apr; 21(4):145-50. PubMed ID: 19342750
[TBL] [Abstract][Full Text] [Related]
7. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Chhatriwalla AK; Bhatt DL
Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
[No Abstract] [Full Text] [Related]
8. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
Costa JR; Abizaid A; Costa R; Feres F; Tanajura LF; Abizaid A; Mattos LA; Staico R; Siqueira D; Sousa AG; Bonan R; Sousa JE
JACC Cardiovasc Interv; 2008 Oct; 1(5):545-51. PubMed ID: 19463357
[TBL] [Abstract][Full Text] [Related]
9. Triple antiplatelet therapy for clopidogrel resistance with stent malapposition: a case report.
Ding FH; Zhang Q; Zhang RY; Hu J; Shen J; Zhao LP; DU R; Zhang X; Shen WF
Chin Med J (Engl); 2009 Sep; 122(18):2186-8. PubMed ID: 19781309
[No Abstract] [Full Text] [Related]
10. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.
Mohammad RA; Goldberg T; Dorsch MP; Cheng JW
Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100
[TBL] [Abstract][Full Text] [Related]
12. Influence of residual stenosis after coronary stent implantation on development of restenosis and stent thrombosis.
Colombo A
Am J Cardiol; 2003 Oct; 92(8):1013; author reply 1013-4. PubMed ID: 14556889
[No Abstract] [Full Text] [Related]
13. Duration of clopidogrel therapy after placement of drug-eluting intracoronary stent.
Spinler SA; Wilensky RL
Am J Health Syst Pharm; 2007 Jul; 64(13):1432-4. PubMed ID: 17592011
[No Abstract] [Full Text] [Related]
14. Subacute coronary stent thrombosis in a patient with angina treated with double antiplatelet drugs for six days.
Xue F; Yang XJ; Cheng XJ; Hui J; Jiang TB; Chen T; Liu ZH; Song JP; Jiang WP
Chin Med J (Engl); 2009 Oct; 122(19):2394-5. PubMed ID: 20079146
[No Abstract] [Full Text] [Related]
15. [The ISAR-SAFE study].
Capranzano P; Castiglioni B
G Ital Cardiol (Rome); 2015 Jun; 16(6):331-5. PubMed ID: 26156693
[No Abstract] [Full Text] [Related]
16. Side balloon stenting of the left main bifurcation: a three-year angiographic follow-up.
Latif F; Heldman AW; Hennebry TA
J Interv Cardiol; 2009 Dec; 22(6):547-9. PubMed ID: 19735474
[TBL] [Abstract][Full Text] [Related]
17. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
[TBL] [Abstract][Full Text] [Related]
18. [Drug-eluting stents--for all, for some or for none?--Editorial].
Kocka V; Widimský P
Vnitr Lek; 2007 Oct; 53(10):1033-4. PubMed ID: 18072425
[No Abstract] [Full Text] [Related]
19. Predictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction.
Brodie B; Pokharel Y; Garg A; Kissling G; Hansen C; Milks S; Cooper M; McAlhany C; Stuckey T
JACC Cardiovasc Interv; 2012 Oct; 5(10):1043-51. PubMed ID: 23078734
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
